about
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of CardioHRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-UpLosartan prevents heart fibrosis induced by long-term intensive exercise in an animal modelArrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation.Comparison of effectiveness of implantable cardioverter defibrillator in patients with idiopathic dilated cardiomyopathy versus those with proved coronary heart disease.Value of the implantable loop recorder for the management of patients with unexplained syncope.Epicardial ablation of syncopal ventricular tachycardia. Utility of the electrocardiogram.Recurrent syncope: an unusual presentation of Brugada syndrome.Diagnosis, management, and outcomes of patients with syncope and bundle branch block.Risk stratification and treatment of brugada syndrome.The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapyStop-gain mutations in PKP2 are associated with a later age of onset of arrhythmogenic right ventricular cardiomyopathy.Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries--data from the European Heart Rhythm Association White Book.Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study.Mapping data predictors of a left ventricular outflow tract origin of idiopathic ventricular tachycardia with V3 transition and septal earliest activation.Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.Long-lasting sport practice and lone atrial fibrillation.Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.Potential proarrhythmic effects of biventricular pacingEndurance sport practice as a risk factor for atrial fibrillation and atrial flutterHRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations.Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialCardiac autonomic control in Brugada syndrome patients during sleep: the effects of sleep disordered breathing.Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mappingLeft ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm.State of the art in forensic investigation of sudden cardiac death.ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs).2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designAtrial fibrillation and atrial flutter in athletes.Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells.Quantification of local changes in myocardial motion by diffeomorphic registration via currents: application to paced hypertrophic obstructive cardiomyopathy in 2D echocardiographic sequences.Electrophysiology: it is time to simplify!The kiss of the girl from Ipanema.
P50
Q24654954-C9E386B5-6A90-428B-B67C-F5B5DFB4E359Q26861465-7386F96C-B8C9-4813-AF6E-791321054154Q28305515-AF5A43E5-1835-4B2B-8D0F-75756724E378Q28485917-BC7E9163-6C6F-4BC7-82CC-89F7B8D5589BQ33144898-C89A5096-0D67-4911-BB6B-A32D54A0E1DAQ33150692-C93F8BC5-3AE2-4BBF-AC0C-DDFF630E8191Q33150846-4BEFFDC9-B696-4F63-9886-A79D22FA0872Q33153759-7AFBCFEE-C753-4E05-B122-BBFAA9B8BF4CQ33154293-DE375066-662D-45C1-BE68-9251ED83ABB8Q33159871-982780BA-5184-4C40-86C0-766CDC5D909EQ33164381-5C5AC0B5-009B-4018-B836-A3BBD4B79CE4Q33552630-C36065F7-C21F-4A8E-842C-AC9154F473D8Q33655317-670CC65B-70C5-4BE5-AE13-D7A1C0CD6EDEQ33803826-7B46DF2D-9C31-44C7-BE7A-7AE2B76E384EQ33812341-4FB817D1-8F49-47B7-BE10-B62E0785FA2BQ33859234-8C5558D0-12B9-4A0E-AD5A-B8705C40D3CBQ34010880-52B5C511-9384-4678-8802-D6B6A73B012FQ34270167-A1D59F4E-E99A-42CB-84ED-31FE31ACC21CQ34368183-436BAC04-3820-43F2-AFF4-1775C8B5E779Q34521282-F36600CD-2610-45D3-B703-05403A58D708Q34891236-899403B8-5C58-45FC-B311-9722C3E6475AQ35035181-095A1992-1CEC-4260-B9A8-ED943F708EA6Q36344676-8AE76365-E744-4B36-8E71-3AB72073851BQ37089770-302A5B40-AB87-46EB-917D-3F465C5D7127Q37190622-21DFAC83-EA0E-4178-8BD2-8546E94A1B3AQ37285957-9D1EA679-B0EA-4F33-8494-347485057558Q37364077-83B82862-8D53-405E-ABCF-448E3B008C64Q37429345-9C0C8D6D-3174-4D4D-8D20-7EC7CD6C4B24Q37474324-85AE8ED5-4FC4-4170-AC81-7B03EB094A71Q37483012-45A8E8C4-C1BF-4469-A131-A2C4AB69B5E8Q37677497-23ED327D-4749-4307-A0F6-1E335D1F8C81Q37978653-4469C173-F357-459C-BCD6-A1E53063BFC1Q37989837-15BDB11E-9C06-41DD-AD24-067124F1C963Q38055465-7BB503ED-19BD-448B-8D31-DFA76EB37E16Q38126693-ED144DE8-EA17-4CF8-ACF6-0B437592EF29Q38134931-5B50B402-AF6A-4B3B-BBA4-139AEB05A7BCQ39304483-9DF06CF5-AE67-42DF-8D91-9F5B74965151Q41741551-631FB5D0-B142-4059-9DC1-837CF389CEC7Q42583132-D42DB831-B888-4323-AB48-BE65B784868CQ43076066-BA3DFD5E-14A8-43A5-ACD3-63F088623DAE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Josep Brugada
@ast
Josep Brugada
@en
Josep Brugada
@es
Josep Brugada
@nl
type
label
Josep Brugada
@ast
Josep Brugada
@en
Josep Brugada
@es
Josep Brugada
@nl
altLabel
JOSEP BRUGADA
@en
prefLabel
Josep Brugada
@ast
Josep Brugada
@en
Josep Brugada
@es
Josep Brugada
@nl
P108
P106
P1153
56524780400
7102917080
P21
P31
P496
0000-0002-5662-8302